-
| ISIN | PLCLNPH00015 |
|---|---|
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector | Healthcare |
| CurrencyCode | PLN |
| Exchange | WAR |
| Target Price | 20 |
|---|---|
| PE Ratio | None |
| Market Cap | 713M |
| Beta | 0.89 |
| Dividend Yield | 2.0% |
Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CLN.WAR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024